Cargando…
Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor agonist, loperamide, administered topically in a liposomal gel formulation on pain, inflammation, and disease progression in the adjuvant-induced model of experimental rheumatoid arthritis in female Lewis r...
Autores principales: | Hua, Susan, Dias, Thilani H., Pepperall, Debbie-Gai, Yang, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539122/ https://www.ncbi.nlm.nih.gov/pubmed/28824428 http://dx.doi.org/10.3389/fphar.2017.00503 |
Ejemplares similares
-
Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery
por: Hua, Susan
Publicado: (2014) -
Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis
por: Hua, Susan, et al.
Publicado: (2016) -
Increased Encapsulation Efficiency of Methotrexate in Liposomes for Rheumatoid Arthritis Therapy
por: Guimarães, Diana, et al.
Publicado: (2020) -
Anti-Rheumatoid Arthritic Effects of Paris Saponin VII in Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes and Adjuvant-Induced Arthritis in Rats
por: Meng, Mei, et al.
Publicado: (2021) -
Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era
por: Ferro, Margarida, et al.
Publicado: (2021)